Instrument NameRegeneron PharmaceuticalsInstrument Symbol(REGN-Q)

Instrument ExchangeNASDAQ

Is it a good time to scoop up last month's biggest losers? Check out October's largest price drops on the Nasdaq, and see whether any of them look like good buys today.

One of these players has split its stock in the past. The other one hasn't.

Micron, Biogen, and Regeneron are three stocks that appear oversold and could present substantial buying opportunities for investors seeking recovery plays.

The biotech needs to overcome an issue most drugmakers face at some point.

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up by +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.47%. Stocks on Tuesday settled higher, with the S&P 500 and Dow...

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.30%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.12%. Stocks today are slightly higher, with the Dow Jones Industrials posting...

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.17%. Stocks today are moderately higher, with the Dow Jones Industrials posting...

/CNW/ -- USA News Group – Optimism is on the rise in fight against cancer, as researchers are making progress across the field of oncology. Helping to spur on...

December S&P 500 E-Mini futures (ESZ24) are up +0.21%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.30% this morning as global risk sentiment got a boost after Beijing announced one of its most aggressive economic stimulus packages since the pandemic.

The S&P 500 Index ($SPX ) (SPY ) Monday closed up by +0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.15%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.31%. Stocks on Monday edged higher, with the Dow Jones Industrials climbing...

Eli Lilly and Regeneron Pharmaceuticals are good stock-split candidates thanks to years of successes.

These stocks have generally delivered competitive returns.

We are looking for Nasdaq 100 companies that were unfairly included in the recent market sell-off

Promising clinical trial results have analysts optimistic about the company’s future.

Would a stock split help lead Regeneron Pharmaceuticals shares higher?

These companies are no strangers to beating the market.

Revenue is climbing at these two drug companies -- and the trend should continue.

Investors shouldn't have to think too hard about these great stocks.

/CNW/ -- After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may...

USA News Group – After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may be experiencing larger per-capita increases in the incidence of leading...

Success has some downsides, including a much higher stock price.